Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

Thousands of people, mainly youngsters and students, donated blood at the 18th Chu nhat do (Red Sunday) blood donation ...

The 18th “Red Sunday” blood donation campaign was launched on Sunday at Hanoi University of Science and Technology, kicking ...

VOV.VN - The 18th edition of Red Sunday, a nationwide voluntary blood donation campaign, was launched at the Hanoi University ...

Cellenkos has received orphan drug designation from the US FDA for its investigational CK0804 Treg therapy to treat ...

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome board-certified medical oncologist and hematologist H. Bindu Lingam, MD to the statewide practice. With nearly 20 years ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...

Find how Circularization for High-throughput Analysis of Nuclease Genome-wide Effects by Sequencing Base Editors ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in ...